SK53794A3 - Method of preparation of 3,7-dihydro-3-alkyl-1h-purine-2,6-diones - Google Patents
Method of preparation of 3,7-dihydro-3-alkyl-1h-purine-2,6-diones Download PDFInfo
- Publication number
- SK53794A3 SK53794A3 SK53794A SK53794A SK53794A3 SK 53794 A3 SK53794 A3 SK 53794A3 SK 53794 A SK53794 A SK 53794A SK 53794 A SK53794 A SK 53794A SK 53794 A3 SK53794 A3 SK 53794A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- alkyl
- methyl
- hydrogenation
- purine
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Abstract
Description
Spôsob prípravy 3, 7-dihydro-3~al kyl~lH~purí.n-2,6-diónovA process for the preparation of 3,7-dihydro-3-alkyl-1H-purine-2,6-dione
Qh.La5..ť„t.admi.kxQh.La5..ť "t.admi.kx
Vynález sa týka spôsobu výroby chemických substancii, konkrétne derivátov xantínu.The invention relates to a process for the production of chemical substances, in particular xanthine derivatives.
ilQiejs^l.4i....Ä.tiay„.„±eLC.bai.Ly.ilQiejs ^ l.4i Ä.tiay .... "." ± eLC.bai.Ly.
Doteraz sa zlúčeniny všeobecného vzorca I vyrábali z východiskovej látky vzorca II redukciou. práškovým zinkom v prostredí kyseliny sírovej /Merck: DRP 161493, T.Ukai:To date, compounds of formula I have been prepared from the starting material of formula II by reduction. zinc powder in sulfuric acid / Merck: DRP 161493, T.Ukai:
J . Pharm.Soc.Japan 74.674,677 (1954)/, redukciou práškovým železom alebo liatinovými pilinami v prostredí vodného roztoku HC1 alebo MH^Cl (E.I.Abramova: Khím.Farm.Zh. 9,/1/, 32,/1975/). Po redukcii sa musí z reakčnej zmesi odstrániť nezreagované redukčné činidlo a potom za pôsobenia kyseliny mravčej a po cyklizácii sa pripraví požadovaná zlúčenina vzorca I. Postup podľa M.F'olonowski a kol.J. Pharm. Soc.Japan 74,674,677 (1954)], by reduction of iron powder or sawdust in an aqueous solution of HCl or MH + Cl (EIAbramova: Khim.Farm.Zh. 9, (1), 32, (1975)) . After reduction, the unreacted reducing agent must be removed from the reaction mixture and then treated with formic acid and cyclized to give the desired compound of formula I. The procedure of M. F. Olonowski et al.
Bul1.Soc.chim. 1946, 80 využíva na redukciu NaaSaOa vo vodnom prostredí, kde pri ďalšom spracovaní sa uvoľňuje veľké množstvo SO2, Podľa Z. Suzuki a kol. Jap.patent 49-81393 sa deriváty xantínu pripravujú redukciou derivátov kyseliny kyanoctovej vo ťormamide za vysokej teploty.Bul1.Soc.chim. 1946, 80 uses NaaSaOa to reduce the aqueous environment, where further processing releases large amounts of SO2. According to Z. Suzuki et al. Japanese Patent No. 49-81393, xanthine derivatives are prepared by reduction of cyanacetic acid derivatives inormamide at high temperature.
Vynález sa týka spôsobu prípravy 3,7-dihydro--3-alky 1-lrl-purín-2,6-diónov vzorcaThe invention relates to a process for the preparation of 3,7-dihydro-3-alkyl 1-1H-purine-2,6-dione of the formula
H-N-H-N
/1/ metyl·, etyl /11/ / 1H . 3 H / -- p y r i m i. d í n d i ó n u v z o r c: a(1) methyl, ethyl (11) (1H). 3 H / - p y r i m. d n n i n v z a a a a a: a
HN·^ .NO kde R je H, metyl, etyl·,n.....propy I, tým spôsobom, že zlúčenina všeobecného vzorca II sa suspenduje vo vode, pridá sa k nej 1 až 5 Z hmôt. hydrogenačného katalyzátora vztiahnutého na hmotnosť zlúčeniny II, obsahujúceho 0,5 až 5 Z Pd alebo 1 až 10 Z Ni vo forme boridu.Zmes sa hy drogériu j e z a intenzívneho miešania pri teplote 20 až 100 °C a tlaku vodíka 0,1 až 3 MF'a, pričom po spotrebovaní ekvimo1árneho množstva vodíka sa k zmesi pridajú 1 až 2 ekvivalenty kyseliny mravčej, ktorá sa nechá pôsobiť pri teplote 20 až 100 0 C počas 1 až S hodín., potom sa zmes zalkalizuje pridaním 1 až 3 ekvivalentov hydroxidu alkalického kovu·, s výhodou NaOH·, ktorý sa nechá pôsobiť pri teplote 30 až 100 o C počas 0,5 až 5 hodín a po úprave pH na hodnotu 5 získa sa filtráciou soľ zlúčeniny vzorca I.Wherein R is H, methyl, ethyl, n-propyl I, by suspending the compound of formula II in water, 1 to 5% by weight is added thereto. hydrogenation catalyst, based on the weight of compound II, containing 0.5 to 5 Z Pd or 1 to 10 Z Ni in the form of a boride. The mixture is mixed with vigorous stirring at 20 to 100 ° C and a hydrogen pressure of 0.1 to 3 MF. and wherein after use ekvimo1árneho amount of hydrogen was added to the mixture 1 to 2 equivalents of formic acid which is treated at 20 to 100 0 C for 1 S hours., then the mixture was made basic by the addition of 1 to 3 equivalents of alkali metal hydroxide · , preferably NaOH ·, which is left to react at 30 to 100 ° C for 0.5 to 5 hours and after adjusting the pH to 5, the salt of the compound of formula I is obtained by filtration.
Uvedenými postupom sa získajú látky všeobecného vzorca I vo vysokom výťažku a vysokej čistoty.The above process yields compounds of formula I in high yield and high purity.
Výhodou podľa vynálezu je to, že hydrogenácia sa uskutočňuje v neutrálnom prostredí,za nízkej teploty a získaný produkt vzorca I s a v y znač u j e v y s o k. o u č d. s t o t o u,,An advantage of the invention is that the hydrogenation is carried out in a neutral environment at low temperature and the product of the formula I obtained is a symbol. o u č d. s t o t o u ,,
FxJJdLacLy........E£syad.ecjLaFxJJdLacLy ........ E £ syad.ecjLa
Príklad 1Example 1
2, S 1 h i' d r o g e n a č n é h o autok Iávu lasarzuje íjj2, S 1 h i d r o g e n o n c h a lavau lasers
1-metyl.....5-n d. trózo-6-aminouracy I u, 100 ml destilovanej vody a 5 g1-methyl ... 5-n d. trose-6-aminouracyl, 100 ml distilled water and 5 g
0,6 % Pd na aktívnom uhlí. Reaktor sa uzavrie a prepláchne 2-krát dusíkom a 2-krát vodíkom,, Po vyhriatí na 60 °C sa za intenzívneho miešania hydrogenuje pri tlaku 0,25 MPa. Po uplynutí 2,5 hodiny sa spotrebuje ekvimolárne množstvo vodíka. Po ochladení na 30 °C sa hydrogenačná zmes vyberie, pridá sa k nej 30 ml 35 Z-nej kyseliny mravčej a zmes sa vyhreje na teplotu 100 °C, pri ktorej sa zmes udržiava ešte 3 hodiny,, Po formylácii sa zmes zalkalizuje pridaním roztoku 40 g hydroxidu sodného v 50 ml destilovanej vody, vyhreje sa na teplotu 85 °C·, pri ktorej sa mieša 1 hodinu. Potom sa z reakčnej zmesi odfiltruje katalyzátor, okyslí sa kyselinou octovou na pH 5 a vyzrážaný produkt sa odfiltruje, premyje vodou a vysuší,, Získa sa 73 g 3-mety 1 ::an t inu, čo predstavuje výťažok 87 Z teórie.0.6% Pd on activated carbon. The reactor is sealed and purged 2 times with nitrogen and 2 times with hydrogen. After heating to 60 ° C, it is hydrogenated under vigorous stirring at 50 psi. After 2.5 hours, an equimolar amount of hydrogen was consumed. After cooling to 30 ° C, the hydrogenation mixture is removed, 30 ml of 35% formic acid are added thereto, and the mixture is heated to 100 ° C, where the mixture is maintained for 3 hours. 40 g of sodium hydroxide in 50 ml of distilled water, heated to 85 ° C, with stirring for 1 hour. The catalyst is then filtered off from the reaction mixture, acidified to pH 5 with acetic acid, and the precipitated product is filtered off, washed with water and dried, yielding 73 g of 3-methyl-aniline.
F' r í k 1 a d 2F 'is 1 and d 2
Zhodný s príkladom 1, s tým rozdielom, že na hydrogenáciu sa použije 10 g NiaB ako katalyzátor. Získa sa 64 g 3-mety1xantinu, čo predstavuje výťažok. 77 Z teórie,Identical to Example 1, except that 10 g of NiaB as catalyst is used for hydrogenation. 64 g of 3-methylxanthine are obtained, which is a yield. 77 From theory,
Príklad 3Example 3
Zhodný s príkladom 1, s tým rozdielom, že hydrogenácia sa robí p ľ i t e ρ 1 o t e 8 0 ° C. Získa sa 66,4 g 3 - me ty 1 x a n t í n u, č o p r e d stav u j e výťažok 80 Ί. teórie.Identical to Example 1, except that the hydrogenation was carried out at 80 ° C. 66.4 g of 3-methyl-1-methanone were obtained, yielding a yield of 80 ° C. theory.
Získané zlúčeniny sa využívajú pri ďalšej syntéze farmaceutický účinných substancií, napr.teobromín. Vynález je využiteľný v chemickom a farmaceutickom priemysle.The compounds obtained are used in the further synthesis of pharmaceutically active substances, for example theobromine. The invention is applicable in the chemical and pharmaceutical industries.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK53794A SK278450B6 (en) | 1994-05-09 | 1994-05-09 | Process for the preparation of 3,7-dihydro-3-alkyl-1h-purine- -2,6-diones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK53794A SK278450B6 (en) | 1994-05-09 | 1994-05-09 | Process for the preparation of 3,7-dihydro-3-alkyl-1h-purine- -2,6-diones |
Publications (2)
Publication Number | Publication Date |
---|---|
SK53794A3 true SK53794A3 (en) | 1995-12-06 |
SK278450B6 SK278450B6 (en) | 1997-06-04 |
Family
ID=20433659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK53794A SK278450B6 (en) | 1994-05-09 | 1994-05-09 | Process for the preparation of 3,7-dihydro-3-alkyl-1h-purine- -2,6-diones |
Country Status (1)
Country | Link |
---|---|
SK (1) | SK278450B6 (en) |
-
1994
- 1994-05-09 SK SK53794A patent/SK278450B6/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK278450B6 (en) | 1997-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3927274B2 (en) | Process for producing N-methyl-N'-nitroguanidine | |
KR100842793B1 (en) | Method for producing ?-methyl-??-nitroguanidine | |
SK53794A3 (en) | Method of preparation of 3,7-dihydro-3-alkyl-1h-purine-2,6-diones | |
NZ241442A (en) | Process for the preparation of 2-amino-6-chloropurine or a 2-acylated derivative thereof and its use as a reaction intermediate for preparing penciclovir or famciclovir | |
JPH1067755A (en) | Production of 4,6-dihydroxypyrimidine | |
WO2022144292A1 (en) | Process for the diastereomerically pure preparation of dl/ld-methionylmethionine | |
FI85010C (en) | Process for the preparation of rimantadine | |
PL185421B1 (en) | Method of obtaining derivatives of aminotriazine | |
US4623730A (en) | Processes for preparing 4-amino-3-imidazolin-2-one and (2-methoxy-2-iminoethyl)urea | |
AU750745B2 (en) | A method of producing aminocyanoacetamide | |
JP3082006B2 (en) | Method for producing 2-alkylthio-4,6-dihydroxypyrimidine | |
US2584024A (en) | 2,4,5-triamino-6-alkoxy pyrimidines and process of preparing same | |
US3857842A (en) | Process for preparing purine compounds by reaction of a carbonitrile with formic acid | |
US6107490A (en) | Process for the manufacture of 4-methyl-5-hydroxymethyl-imidazole | |
HU199414B (en) | Process for producing substituted indolinone derivatives | |
CA1330080C (en) | Process for precipitating cytosine from alkaline solutions with sulphuric acid | |
Hitchings et al. | Isomeric Dihydroxanthopterins | |
PL209729B1 (en) | Method for the manufacture of 2-[(2, 3, 4-trihydroxiphenyl) methyl) hydrazide D , L-serine hydrochloride | |
US5688947A (en) | Production of purines via reductive formylation | |
WO1995022531A1 (en) | Process for producing 6-substituted 2(1h)-quinoxalinone | |
US3929788A (en) | Synthesis of 4,5-diaminouracil and its salts | |
US5264573A (en) | Process for preparing 2-chloro-1,7-dihydropurin-6-one and a process for its purification | |
US5097030A (en) | Process for the preparation of 2-(methylthio)barbituric acid | |
EP1144358A3 (en) | Process for production of 2-amino-1,3-propanediol | |
KR0169984B1 (en) | Process for the recuperation of approximately non-fluorescent xanthines |